Does ASPIRIN Cause Myelofibrosis? 46 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Myelofibrosis have been filed in association with ASPIRIN (Aspirin). This represents 0.1% of all adverse event reports for ASPIRIN.
46
Reports of Myelofibrosis with ASPIRIN
0.1%
of all ASPIRIN reports
7
Deaths
27
Hospitalizations
How Dangerous Is Myelofibrosis From ASPIRIN?
Of the 46 reports, 7 (15.2%) resulted in death, 27 (58.7%) required hospitalization.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ASPIRIN. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does ASPIRIN Cause?
Gastrointestinal haemorrhage (13,172)
Anaemia (4,568)
Off label use (4,283)
Dyspnoea (4,280)
Drug hypersensitivity (4,072)
Drug ineffective (4,061)
Upper gastrointestinal haemorrhage (3,411)
Epistaxis (3,214)
Rectal haemorrhage (3,057)
Acute kidney injury (2,976)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
RITUXIMAB (43)
ANAGRELIDE (41)
ELTROMBOPAG OLAMINE (39)
Which ASPIRIN Alternatives Have Lower Myelofibrosis Risk?
ASPIRIN vs ASPIRIN DL-LYSINE
ASPIRIN vs ASPIRIN LYSINE
ASPIRIN vs ASPIRIN\BUTALBITAL\CAFFEINE
ASPIRIN vs ASPIRIN\CAFFEINE
ASPIRIN vs ASPIRIN\CARISOPRODOL